André Scheen

15PUBLICATIONS
9CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionPharmacogenomicsCardiology (incl. cardiovascular diseases)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 25, 2026
Safety of SGLT2 inhibitors for patients with type 2 diabetes: where are we now?

|Mar 19, 2026
GLP-1-derived therapies and risk of sarcopenia: myth or reality?

André J Scheen

|Jun 30, 2025
Progress towards a personalized management of antidiabetic medications in the elderly with type 2 diabetes.

A J Scheen

|May 14, 2025
Glucagon-like peptide-1 receptor agonists and alcohol use disorders: An emerging unexpected beneficial effect.

André J Scheen

|Sep 28, 2024
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy.

André J Scheen

|Sep 02, 2024
[Underuse of SGLT2 inhibitors in clinical practice].

André J Scheen

Pageof 3

Frequent Collaborators

1 joint publications

Nicolas Paquot

1 joint publications

Serge Jabbour

1 joint publications

Kamel Mohammedi

1 joint publications

Pierre Gourdy